Results 21 to 30 of about 8,921 (227)

Self unbound: ego dissolution in psychedelic experience [PDF]

open access: yes, 2017
Users of psychedelic drugs often report that their sense of being a self or ‘I’ distinct from the rest of the world has diminished or altogether dissolved.
Gerrans, Philip, Letheby, Chris
core   +2 more sources

The varieties of the psychedelic experience: A preliminary study of the association between the reported subjective effects and the binding affinity profiles of substituted phenethylamines and tryptamines [PDF]

open access: yes, 2018
Classic psychedelics are substances of paramount cultural and neuroscientific importance. A distinctive feature of psychedelic drugs is the wide range of potential subjective effects they can elicit, known to be deeply influenced by the internal state of
Erowid, Earth   +6 more
core   +2 more sources

Histoire du LSD. De l’ergot de seigle à l’utilisation thérapeutique [PDF]

open access: yes, 2015
National audienceLe LSD, de l’allemand Lysergsäurediethylamid, est une substance hallucinogène utilisée à but récréatif. Également connue sous le nom d’« acide », cette molécule à propriétés psychotropes est classée en France comme un stupéfiant illicite
Gicquel, Thomas   +2 more
core   +3 more sources

Over 30 million psychedelic users in the United States [v1; ref status: indexed, http://f1000r.es/w8]

open access: yesF1000Research, 2013
We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older.
Teri S Krebs, Pål-Ørjan Johansen
doaj   +1 more source

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

open access: yesFrontiers in Psychiatry, 2020
BackgroundObservational data and preliminary studies suggest serotonin 2A agonist psychedelics may hold potential in treating a variety of substance use disorders (SUDs), including opioid use disorder (OUD).AimsThe study aim was to describe and analyze ...
Albert Garcia-Romeu   +7 more
doaj   +1 more source

LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1

open access: yesScientific Reports, 2021
Recent evidence suggests that psychedelic drugs can exert beneficial effects on anxiety, depression, and ethanol and nicotine abuse in humans. However, their hallucinogenic side-effects often preclude their clinical use.
Ramona M. Rodriguiz   +6 more
doaj   +1 more source

LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality [PDF]

open access: yes, 2016
Lysergic acid diethylamide (LSD) is used recreationally and has been evaluated as an adjunct to psychotherapy to treat anxiety in patients with life-threatening illness.
CG Frye   +42 more
core   +1 more source

LSD-induced changes in the functional connectivity of distinct thalamic nuclei

open access: yesNeuroImage, 2023
The role of the thalamus in mediating the effects of lysergic acid diethylamide (LSD) was recently proposed in a model of communication and corroborated by imaging studies.
Stefano Delli Pizzi   +12 more
doaj   +1 more source

Modern Clinical Research on LSD [PDF]

open access: yes, 2017
All modern clinical studies using the classic hallucinogen lysergic acid diethylamide (LSD) in healthy subjects or patients in the last 25 years are reviewed herein. There were five recent studies in healthy participants and one in patients.
A Garcia-Romeu   +85 more
core   +1 more source

Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects [PDF]

open access: yes, 2016
Lysergic acid diethylamide (LSD) is a serotonin 5-hydroxytryptamine-2A (5-HT2A ) receptor agonist that is used recreationally worldwide. Interest in LSD research in humans waned after the 1970s, although the use of LSD in psychiatric research and ...
Armario   +56 more
core   +1 more source

Home - About - Disclaimer - Privacy